Asian Stock Market: Trades mixed as China, covid woes probe bulls

  • Asian equities track Wall Street amid mixed catalysts, cautious mood.
  • China’s fresh salvo on technology company, coronavirus jitters challenge bulls.
  • Receding fears of Fed’s tapering, vaccine optimism keeps buyers hopeful.

Asian shares fail to portray clear market direction as concerns over China and the latest jump in the virus numbers weigh on the earlier optimism amid a light calendar on Thursday.

China’s run of disappointing data doesn’t stop Beijing from regulatory assaults on the technology companies, which in turn weigh on the dragon nation’s equities and spills over the Asia-Pacific region.

A record jump in Australia’s daily covid cases, by 1,466 cases for Wednesday, per the latest data from ABC News, joins worrisome virus numbers from New Zealand and the UK to challenge the previous optimism. It’s worth noting that Japan is also up for extending the virus-led state of emergency in Tokyo and 20 other prefectures by another two weeks.

Amid these plays, MSCI’s index of Asia–Pacific shares outside Japan rise 0.37% on a day whereas Japan’s Nikkei 225 pays a little heed to chatters over the extended emergencies in the key prefectures to print a 0.25% upside on a day.

China prints mixed numbers and Australia drops 0.80% despite strong Aussie trade numbers. Further, traders from New Zealand follow PM Jacinda Ardern’s hopes of overcoming the pandemic even as infections jump past 700 levels.

Bank of Korea’s Governor Lee Ju-yeol couldn’t save KOSPI, down 1.0% by the press time whereas Indonesia’s IDX Composite drops 0.30% amid mildly offbeat markets. On the contrary, India’s BSE Sensex prints mild gains even as the country reports the highest daily infections since early July.

On a broader front, Germany’s Bundesbank President Jens Weidmann backed the ECB tapering chatters on the bloc’s recently upbeat statistics whereas softer signals for the US jobs report hint at delayed tapering by the US Federal Reserve (Fed). Additionally, the Western leaders are pushing for more vaccines and booster shots while the World Health Organization (WHO) cites the risk of another virus variant that is vaccine-resistant.

Amid these plays, S&P 500 Futures and the US 10-year Treasury yields remain pressured, mostly unchanged, while the US Dollar Index (DXY) keeps late Wednesday’s bounce off monthly low.

Read: US Stocks Forecast: This could be blue skies for Wall Street, tech leads the way

Moving on, the US Q2 Nonfarm Productivity, Weekly Jobless Claims and Factory Orders for July will be watched to clarify downbeat forecasts of the US Nonfarm Payrolls (NFP) and propel the markets should the actual data softens.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Feed news

How do emotions affect trade?
Follow up our daily analysts guidance

Subscribe Today!    

Latest Forex News

Latest Forex News

Editors’ Picks

EUR/USD slides under 1.16 as US Retail Sales smash estimates

EUR/USD is trading under 1.16 after US Retail Sales smashed estimates with 0.7% in September. Treasury yields are rising. The risk-on mood continues to underpin the pair, as the ECB policymaker Wunsch dismisses inflation concerns. 


GBP/USD retreats below 1.3750 after US data

GBP/USD has pared some of its gains after US Retail Sales beat estimates, with the core group hitting 0.8% last month. Earlier, investors shrugged off dovish comments from two BOE members. 


XAU/USD slumps to $1,770 area on upbeat US data, surging US bond yields

Gold started the last day of the week on the back foot and extended its slide to a fresh daily low of $1,770 in the early trading hours of the American session pressured by the dollar's resilience and surging US Treasury bond yields.

Gold News

Crypto bulls on winning streak pushing for more

Bitcoin price favors bulls reaching $60,000 by the end of this week and onwards to new all-time highs by the end of next week. Ethereum price broke a bearish top line and could hit new all-time highs by next week in tandem with Bitcoin. 

Read more

Why is Tesla going up?

Tesla's (TSLA) stock price has finally pushed higher in a series of steady and sure moves. We had nearly given up on our bullish call with Tesla stock as it kept struggling around the $800 level.

Read more